Table 1

Comparison of cases with endometrioid carcinoma and proliferative endometrium
IHS score Endometrioid Proliferative Pvalue
carcinoma endometrium
(n = 47) (n = 10)
Fascin 0 13 (27.7%) 7 (70.0%) p = 0.023
≤10 27 (57.4%) 3 (30.0%)
≥11 7 (14.2%) 0 (0%)
CD44v6 0 25 (53.2%) 6 (60.0%) p = 0.542
≤10 19 (40.4%) 4 (40%)
≥11 3 (6.4%) 0 (0%)

IHS: immunohistochemical score.

Gun et al.

Gun et al. Diagnostic Pathology 2012 7:80   doi:10.1186/1746-1596-7-80

Open Data